Month: November 2013

Last year the world’s eighth largest drug maker Johnson & Johnson agreed to pay billions of dollars to resolve allegations it inappropriately promoted the antipsychotic drug Risperdal, which was one of the company’s best-selling drugs.  The investigations stretch back ten years and puts the agreement as the third-largest pharmaceutical settlement in the United States. However, […]

In mesothelioma litigation, a person who has cancer from exposure to asbestos hires specialized attorneys to seek compensation for damages. Mesothelioma is a rare form of cancer that attacks the linings of some of the internal organs of a person. This disease is very deadly and moves quickly once it starts. However, it can take […]

Some dangerous dialysis medications have prompted lawsuits by many patients, with claims that the drugs were responsible for serious health concerns, including fatal heart failure. Specifically, Fresnius Medical Care’s Granuflo and Naturalyte are responsible for serious adverse effects and have been recalled by the FDA as a result. This recall, which started in March 2012, […]

The linkage between mesothelioma and asbestos has been firmly established by doctors and the vast majority of patients suffering from this form of cancer have been exposed to the material at some point. It was a popular building material in the late 19th century and wasn’t phased out until the 1980s. It was also used […]

Though dextropropxyphene and the medications that contain it have been around for decades, the FDA instituted a Darvocet recall in November, 2012. Until 2009, the agency had considered the medication to be safe for general use, but after reviewing compiled statistics provided by medical examiners around the country, this opinion changed. Now, this drug has […]